Bryostatin 1
草苔虫内酯１
Report date: 2026/04/03 20:03:44
Base Information
Drug NameBryostatin 1
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[47]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeurotrope Bioscience IncWest Virginia University
China Registration ClassN/A
Develop Information
Active CompaniesBryologyx IncNeurotrope Bioscience Inc
Inactive CompaniesDana-Farber Cancer InstituteBarbara Ann Karmanos Cancer InstituteThe University Of Chicago +[13]
Active Indications
Inactive Indications +[46]